Format

Send to

Choose Destination
Bone Marrow Transplant. 2017 Apr;52(4):646-649. doi: 10.1038/bmt.2016.338. Epub 2016 Dec 19.

Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.

Author information

1
Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
2
Department of Research, Cancer Registry of Norway, Oslo, Norway.
3
Department of Cardiology, Oslo University Hospital, Oslo, Norway.
4
Department of Oncology, Oslo University Hospital, Oslo, Norway.
5
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
6
Department of Cardiology, St Olavs University Hospital, Trondheim, Norway.
7
Department of Respiratory Medicine, Oslo University Hospital, Oslo, Norway.
PMID:
27991891
DOI:
10.1038/bmt.2016.338
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for Norwegian BIBSYS system
Loading ...
Support Center